Search results
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 4 days agoCyanVac has received US federal funding through the Project NextGen initiative to conduct a Phase...
A nasal vaccine could be key in curbing the spread of COVID-19
The Hill via Yahoo News· 2 years agoStory at a glance A nasal vaccine could be another weapon in the arsenal against COVID-19. Early...
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line
Politico via Yahoo News· 2 years agoBiden administration officials are raising concerns that the slow pace of developing a nasal vaccine...
Ocugen Inks US Development Pact For Its Intranasal COVID-19 Vaccine
Benzinga via Yahoo Finance· 2 years agoOcugen Inc (NASDAQ: OCGN) has entered into an exclusive license agreement with Washington University...
Two years later, did Covid vaccines live up to their promise?
NBC Universal via AOL· 2 years agoDespite the success of mRNA shots, researchers think we could do better with a new generation of...
Why the U.S. Doesn’t Have a Nasal Vaccine for COVID-19
Time via Yahoo News· 2 years agoCredit - Illustration by Alex Nabaum for TIME The U.S. led the world in quickly developing COVID-19...
Oxford/AstraZeneca COVID vaccine nasal spray fails in trial
Fortune via Yahoo Finance· 2 years agoThe nasal version of the Oxford/AstraZeneca COVID vaccine failed to elicit an antibody response in...
The era of needle-free COVID vaccines may be beginning as India approves its first nasal spray
Fortune via Yahoo Finance· 2 years agoIndia’s drug regulator authorized the country’s first nasal spray vaccine on Tuesday, marking a big...
China approved a COVID-19 vaccine mist that can be inhaled: the first needle-free booster option
Business Insider via Yahoo News· 2 years agoFILE PHOTO: A man receives an influenza vaccine via nasal mist.Getty/TIM SLOAN / Staff A COVID-19...
COVID-19 vaccines: From nasal drops to a redesign, what 2023 could have in store
CBS News via Yahoo News· 1 year agoPivotal results on a variety of next generation approaches are expected soon, as a panel of FDA...